Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2346486 Target Snapshot

Nicotinamide N-methyltransferase · SINGLE PROTEIN · Homo sapiens

360Compounds
108Assays
0Approved Drugs
406.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P40261. Use UniProt P40261 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P40261 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Nicotinamide N-methyltransferase as ChEMBL target CHEMBL2346486, mapped to UniProt P40261. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Nicotinamide N-methyltransferase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2346486
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P40261
Nicotinamide N-methyltransferase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Nicotinamide N-methyltransferase is the right protein anchor across sources, using UniProt P40261 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNicotinamide N-methyltransferase
UniProt AccessionP40261
Component TypeProtein
Sequence Length264 aa

Nicotinamide N-methyltransferase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Nicotinamide N-methyltransferase, mapped to UniProt P40261. Sequence length is 264 aa.

Mapped IDP40261
Review nameNicotinamide N-methyltransferase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Phase II
Assay Mix

Activity Type Distribution

IC50298.0
KI99.0
KD9.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4867273 9.82 IC50 0.15 Preclinical
CHEMBL4553052 9.72 Ki 0.1905 Preclinical
CHEMBL4580446 9.62 Ki 0.2399 Preclinical
CHEMBL4859806 9.4 IC50 0.4 Preclinical
CHEMBL4847740 9.33 IC50 0.47 Preclinical
CHEMBL4591248 9.3 Ki 0.5 Preclinical
CHEMBL4857394 9.03 IC50 0.93 Preclinical
CHEMBL4878738 8.96 IC50 1.1 Preclinical
CHEMBL5194905 8.96 IC50 1.1 Preclinical
CHEMBL5408922 8.92 Ki 1.2 Preclinical
Distribution

pChEMBL Value Distribution

42
5.0
41
5.5
33
6.0
35
6.5
44
7.0
17
7.5
13
8.0
17
8.5
5
9.0
3
9.5
pChEMBL
Assay Landscape

Assay Landscape

108
Total Assays
216
Tested Compounds
1
Assay Types
Binding — 108 assays, 216 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 43 76 6.3
assay format 36 49 6.3
single protein format 27 91 6.5
subcellular format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine